U.S. Hemostasis Valve Market Witnesses Strong Momentum with Innovative Vascular Access Technologies
The U.S. hemostasis valve market, valued at USD 67.79 million in 2024, is projected to grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2034, reflecting a robust demand trajectory driven by rising interventional cardiology and vascular procedures. While the U.S. remains the central hub for innovation and adoption, regional dynamics across North America, Europe, and the Asia...
0 Kommentare 0 Geteilt 80 Ansichten 0 Bewertungen
Gesponsert